We previously established a potential role for cocaine and amphetamine regulated transcript (CARTPT) in dominant follicle selection in cattle. CARTPT expression is elevated in subordinate versus dominant follicles, and treatment with the mature form of the CARTPT peptide (CART) decreases follicle-stimulating hormone (FSH)-stimulated granulosa cell estradiol production in vitro and follicular fluid estradiol and granulosa cell CYP19A1 mRNA in vivo. However, mechanisms that regulate granulosa cell CART responsiveness are not understood. In this study, we investigated hormonal regulation of granulosa cell CART-binding sites in vitro and temporal regulation of granulosa cell CARTbinding sites in bovine follicles collected at specific stages of a follicular wave. We also determined the effect of inhibition of CART receptor signaling in vivo on estradiol production in future subordinate follicles. Granulosa cell CART binding in vitro was increased by FSH, and this induction was blocked by estrogen receptor antagonist treatment. In follicles collected in vivo at specific stages of a follicular wave, granulosa cell CART binding in the F2 (second largest), future subordinate follicle increased during dominant follicle selection. Injection into the F2 follicle (at onset of diameter deviation) of an inhibitor of the o/i subclass of G proteins (previously shown to block CART actions in vitro) resulted in increased follicular fluid estradiol concentrations in vivo. Collectively, results demonstrate hormonal regulation of granulosa cell CART binding in vitro and temporal regulation of CART binding in subordinate follicles during dominant follicle selection. Results also suggest that CART signaling may help suppress estradiol-producing capacity of the F2 (subordinate) follicle during this time period. atresia, bovine, cocaine and amphetamine regulated transcript (CART), estradiol/estradiol receptor, follicular development, granulosa cell, ovary
INTRODUCTION
Follicular growth occurs in a characteristic wave-like pattern in cattle and other monotocous species [1] . A transient increase in follicle-stimulating hormone (FSH) triggers initiation of each follicular wave [2] [3] [4] . Emergence is defined as the first day that a new follicle 4 mm or larger in diameter is detected by ultrasonography and is the first chronological event marking a new follicular wave. After emergence, follicles in the cohort initially grow at a similar rate (common growth phase) [5] . Diameter deviation is defined as the divergence in growth rates between the two largest follicles in a follicular wave, during which time the largest (F1; future dominant) continues to grow and the second largest (F2; future subordinate) follicle experiences reduced growth rate and estradiol production [5] . The onset of diameter deviation (hereafter referred to as onset of deviation) occurs when the F1 follicle reaches at least 8.5 mm in diameter in cattle and also marks initiation of divergence in estradiol-producing capacity between the F1 and F2 follicles, resulting in acquisition of dominance and completion of dominant follicle selection [5] . Molecular determinants predictive of the F1 follicle, such as low IGFBP4 concentrations, have been identified [6] , but follicle ablation studies have demonstrated that all follicles in the cohort retain the capacity to become the dominant follicle during the common growth phase [5] . The endocrine and local regulatory mechanisms involved in selection of the dominant follicle during follicular waves are not entirely understood.
Recent results demonstrate that the cocaine and amphetamine regulated transcript (CARTPT) gene is a novel regulator of ovarian function during follicular waves in cattle [7] . CARTPT encodes for a small peptide hormone that was first discovered in the brain with more limited expression in peripheral tissues. Within the central nervous system, neuroendocrine [8] [9] [10] , antipsychostimulant [11] , and anorexigenic [12] [13] [14] actions of the mature form of CARTPT (CART) have been documented. CARTPT expression was discovered in the ovary through sequencing of expressed sequence tags in a bovine oocyte cDNA library [15] , and it is robustly expressed in the granulosa cells of bovine antral follicles [16] .
Abundance of CARTPT mRNA is elevated in follicles that are estrogen inactive (atretic) as compared to estrogen active (healthy) follicles in the predeviation (before dominant follicle selection) and early dominance (after selection) stages of the follicular wave [17] . Treatment with CART reduces FSH [18] and IGFI [7] -stimulated granulosa cell estradiol production in vitro and reduces follicular fluid estradiol when administered into dominant follicles in vivo [17] . Treatment with CART in vitro also decreases luteinizing hormone (LH)-stimulated androstenedione production by thecal tissue collected from predeviation and early dominant follicles [17] . The inhibitory effects of CART on follicular estradiol production are mediated through alterations in the gonadotropin signaling cascade as addition of CART decreases FSH-stimulated cAMP production as well as FSH-stimulated Ca 2þ influx [18] and results in early termination of FSH-induced MAPK1/3 signaling [19] . Evidence also supports hormonal regulation of CARTPT expression. Treatment with FSH or IGF1 decreases granulosa cell CARTPT mRNA in vitro [17] . Taken together, these results suggest a potential role for CARTPT in selection of the dominant follicle.
Evidence from a variety of systems suggests biological actions of CART are receptor mediated, despite the fact that the molecular identity of the CART receptor has not been established. Binding of a CART-GFP fusion protein to HepG2 cells and dissociated hypothalamic cells has been reported previously [20] . Specific saturable binding of CART peptides to AtT20 cells [21] , PC12 cells [22] , and primary cultures of cells from rat nucleus accumbens [23] have been demonstrated, and CART binding is reduced in the presence of GTP, but not ATP, analogues [23] . Furthermore, actions of CART on granulosa cells [18, 19] , AtT20 cells [24] , and hippocampal neurons [25] are abrogated by pretreatment of cells with an inhibitor of the o/i subclass of inhibitory G proteins (G o/i ) linked to CART receptor signaling. Collectively, evidence indicates CART actions are presumably mediated via a G protein-coupled receptor.
We hypothesize that CART signaling is a major regulator of estradiol-producing capacity of the F2 follicle during dominant follicle selection. However, whether granulosa cell CART binding is hormonally regulated and temporal changes in CART binding during follicular waves help target CART's actions specifically to subordinate follicles are not known. Nor have the effects of inhibition of CART action on follicular steroidogenesis in vivo near the time of dominant follicle selection been determined. Thus, the present study was conducted to examine temporal regulation of CART binding in dominant and subordinate bovine follicles collected at specific time points encompassing dominant follicle selection and to determine hormonal regulation of granulosa cell CART binding in vitro. Studies were also conducted to determine whether inhibition of G o/i protein activity linked to CART receptor signaling enhances estradiol production by the F2 follicle in vivo near the time of dominant follicle selection.
MATERIALS AND METHODS

Animals
All animal procedures were performed with approval of the Michigan State University Institutional Animal Care and Use Committee. Nonlactating Holstein dairy cows received two injections of prostaglandin F2a, given 14 days apart, to synchronize their estrous cycles and were randomly assigned to a treatment or time point group. Beginning 2 days after the second prostaglandin F2a injection, ovaries were scanned two or three times daily to monitor ovulation and initiation and growth of the first wave of follicles. At specific stages of the first follicular wave (detailed below), cattle were subjected to either ovariectomy or ultrasound-mediated intrafollicular injection followed by follicular fluid aspiration [26] .
Ovariectomy and Granulosa Cell Collection
Ovaries were collected by colpotomy at the following stages of the first follicular wave (Fig. 1) : predeviation (1.5 days after the first ultrasound scan were a new follicle !4 mm in diameter was detected) and onset of deviation
Graphical depiction of experimental model used for collection of ovarian follicles at specific stages of a follicular wave. Granulosa cells were isolated from the F1 and F2 follicles from ovaries collected at the following stages of the first follicular wave: predeviation (1.5 days after emergence, defined as the first ultrasound scan where a new follicle !4 mm is detected), onset of deviation (first scan where growth of the F1 follicle to !8.5 mm is detected and the F2 follicle is still growing), and early dominance (first scan where one follicle in a cohort is 2 mm larger than the others).
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(first scan where growth of the F1 follicle to !8.5 mm was detected and the F2 follicle was still growing). Diameter deviation is defined as the divergence in growth rates between the two largest follicles in a follicular wave, during which time the F1 follicle continues to grow and the F2 follicle experiences reduced growth rate and estradiol production [5] . The onset of deviation occurs when the F1 follicle reaches 8.5 mm and marks initiation of divergence in growth rate and estradiol-producing capacity between the F1 and F2 follicles [5] , resulting in acquisition of dominance. Ovaries were also collected at early dominance stage (first scan where one follicle in the cohort was 2 mm larger than the others). Granulosa cells and follicular fluid were isolated from the F1 and F2 follicles and follicular fluid immediately frozen and stored at À808C. For CART-binding studies, granulosa cells were lysed in 50 mM Tris buffer, and the crude membrane fraction was pelleted by centrifugation (17 000 3 g for 45 min at 84C). The membrane preparation was then stored at À808C until CARTbinding assay was performed.
Iodination of CART
The CART (61-102; American Peptide Company) was labeled with 125 I (PerkinElmer) using Pierce iodination tubes for 15 min according to the manufacturer's instructions. Radiolabeled CART was separated from the free iodine using polyacrylamide desalting columns (Pierce) and stored at À208C in Dulbecco PBS (DPBS) containing 1 mg/ml of protease-free bovine serum albumin (BSA; Sigma-Aldrich) and protease inhibitors (Roche). Iodinated CART had a specific activity of approximately 8 Ci/mmol.
CART Membrane-Binding Assays
Membrane preparations were resuspended in DPBS containing 1 mg/ml of protease-free BSA and protease inhibitors. Membranes were incubated at 378C for 1 h with 125 I-labeled CART peptide (;0.7 lM; 1 3 10 6 CPM) in the presence (two tubes) or absence (two tubes) of 5 lM unlabeled CART peptide (7-fold molar excess; 55-102; American Peptide Company). Membranes were washed twice with DPBS supplemented as described above, and total and specific CART binding were determined for each membrane preparation. Amount of specific binding was adjusted per milligram of total protein in the membrane preparations (determined using the Bio-Rad DC Protein Assay per the manufacturer's instruction). The optimum temperature, incubation time, and total amount of labeled CART per tube for use in binding assays were determined in preliminary studies. The optimized whole cell-binding assay (described below) was then used to quantify specific saturable CART binding on freshly isolated as well as cultured granulosa cells. Preliminary experiments also demonstrated that a similar amount of CART binding was obtained using membrane preparations or the whole cell-binding assay.
Hormonal Regulation of Granulosa Cell CART Binding In Vitro
Hormonal regulation of granulosa cell CART binding in vitro was determined using an established culture system in which we previously demonstrated [18, 27] that cells display increased estradiol production with time in culture and respond to FSH with a dose-dependent increase in estradiol. Briefly, granulosa cells were isolated and pooled from follicles (diameter, 3-5 mm) harvested from ovaries collected at an abattoir. The granulosa cells were washed three times in medium (Minimum Essential Mediuma; Invitrogen) containing insulin, IGF1, transferrin, sodium selenite, androstenedione (all from Sigma), penicillin-streptomycin, and fungizone (Invitrogen). Granulosa cells (100 000 live cells/well) were plated in 96-well culture dishes (BD Biosciences) containing the treatments described below, with medium replaced every 2 days. Cells (100 000 live cells/well, 48 wells/treatment) were cultured in the presence of increasing concentrations of FSH (0, 0.1, 0.5, 5, and 25 ng/ ml; National Hormone and Peptide Program) or in the presence of 0.5 ng/ml of FSH with or without the estrogen receptor antagonist ICI 182 780 (1 lM; Sigma-Aldrich). The dose of ICI 182 780 selected was based on results of previously published dose-response studies [28] . After 6 days of culture, medium was harvested for estradiol assay and cells trypsinized and counted or subjected to whole-cell CART-binding assay. Each experiment was repeated four or five times on different days using different pools of granulosa cells.
Whole-Cell CART-Binding Assay
For CART-binding assay on cultured cells, granulosa cells were removed from the culture plate and pooled (12 wells/tube). The cells were then centrifuged (400 3 g for 10 min at 84C) and resuspended in DPBS containing 1 mg/ml of protease-free BSA and protease inhibitors. Cells were incubated at 378C for 1 h with 125 I-labeled CART peptide (;0.7 lM; 1 3 10 6 CPM) in the presence (one tube) or absence (two tubes) of 5 lM unlabeled CART peptide (;7-fold molar excess). After centrifugation (400 3 g for 10 min at 84C), cells were washed twice with DPBS, and total and specific CART binding was determined for each treatment. Amount of specific binding was adjusted per 100 000 cells, and data are presented as fold-change relative to control cells cultured in the absence of above-described treatments (medium alone).
Effect of Intrafollicular G o/i Inhibitor Administration In Vivo on Granulosa Cell Estradiol Production
To begin to address the potential functional requirement of granulosa cell CART in regulation of estradiol-producing capacity of the F2 follicle during dominant follicle selection, intrafollicular injection studies were conducted in vivo. At onset of deviation (OD in Fig. 1 ), the F2 follicle was injected with the G o/i inhibitor NF023 (n ¼ 5 animals; EMD Chemicals) linked to CART receptor signaling [18, 19, 24, 25] or an inactive form of the same inhibitor (NF027; control; n ¼ 4 animals; EMD Chemicals) using an ultrasound-guided injection technique (final intrafollicular concentration, 100 lM) as previously described [29] . Preliminary studies tested effects of different doses of NF023 on follicular fluid estradiol concentrations. The onset of deviation stage was selected to test the effect of inhibition of CART signaling on steroidogenic capacity of the F2 follicle, both because the expected time of onset of deviation in cattle is well established [5] and because previous studies showed that the F2 follicle at this stage of the predominance phase is still healthy and able to grow and become dominant after ablation of the F1 follicle [30, 31] . At 24 h after injection, the injected follicles were aspirated using an ultrasound-guided needle [32] , and the follicular fluid was centrifuged (3000 3 g for 5 min at room temperature) and stored at À808C until assayed for estradiol and progesterone.
Estradiol, Progesterone, and CART Assays
Estradiol and progesterone concentrations were determined in follicular fluid and medium samples via radioimmunoassay per the manufacturer's instructions (Siemens Health Care Diagnostics). Intra-and interassay coefficients of variation were 6.7% and 7.2%, respectively, for estradiol and 5.3% and 8.5%, respectively, for progesterone. Health status of follicles collected was then determined based on follicular fluid steroid concentrations. Follicles with an estradiol:progesterone ratio of 1 or greater are estrogen active and healthy, and follicles with an estradiol:progesterone ratio of less than 1 are estrogen inactive and atretic [33] [34] [35] . Follicular fluid CART peptide concentrations were measured in a single assay using a previously validated [17] commercial kit (CART [55-102] RIA kit; Phoenix Pharmaceuticals) according to the manufacturer's protocol, with an intra-assay coefficient of variance of 9.1%.
Statistical Analyses
Effects of stage of follicular wave and follicle classification (F1 vs. F2) on granulosa cell CART binding, follicle size, and follicular fluid estradiol and progesterone concentrations were analyzed using a two-factor ANOVA with Proc GLM in SAS 9.2 (SAS Institute, Inc.). The interaction term was then subjected to slicing [36] to determine the simple effects of stage of the follicular wave and of follicle classification (F1 vs. F2) on granulosa cell CART binding and other parameters of interest. CART binding and estradiol production in vitro were analyzed using a one-way ANOVA by Proc GLM in SAS 9.2 with log transformation if required for normality of data. Differences in follicular fluid hormone concentrations of follicles injected with the inhibitor of G o/i signaling (NF023) versus the inactive form of the inhibitor (NF027) were analyzed using a Student t-test. Data are presented untransformed except where noted in the figure legends.
RESULTS
Hormonal Regulation of Granulosa Cell CART Binding In Vitro
Treatment of cultured granulosa cells with FSH increased estradiol production and CART binding in a biphasic, dosedependent manner (P , 0.05). Doses up to 0.5 ng/ml increased both estradiol concentrations in medium ( Fig. 2A) and granulosa cell CART binding (Fig. 2B) , but doses greater then 0.5 ng/ml decreased both parameters (Fig. 2) . Whereas FSH (0.5 ng/ml) significantly increased both estradiol production and CART binding compared to medium alone, the addition of CART RECEPTOR BINDING AND FOLLICULAR ATRESIA the estrogen receptor antagonist ICI 182 780 completely blocked the FSH-induced increase in estradiol production (P , 0.05) (Fig. 3A) . Treatment with ICI 182 780 also totally blocked the FSH-induced increase in granulosa cell CART binding and further reduced CART binding by 95% compared to untreated (control) cells (P , 0.05) (Fig. 3B ).
Temporal Regulation of Granulosa Cell CART Binding During a Follicular Wave
Follicle size was increased (significant effect of stage of the follicular wave, P , 0.01) for the F1 and F2 follicles during progression of the first follicular wave (Fig. 4A) . Follicular fluid concentrations of estradiol and the estradiol:progesterone ratio were increased (significant effect of stage of the follicular wave, P , 0.05) for the F1, but not the F2, follicle accompanying dominant follicle selection (Fig. 4, B and C) , whereas follicular fluid concentrations of CART were decreased in the F1 follicle (P , 0.05) during this time period (Fig. 4D) . Furthermore, divergence in follicular fluid estradiol, progesterone, estradiol:progesterone ratios, and CART concentrations between the F1 and the F2 follicle was only noted in follicles collected at the early dominance stage (P , 0.05). An effect of stage of the follicular wave on follicular fluid CART concentrations in F2 follicles was not observed.
A significant effect of stage of the follicular wave on granulosa cell CART binding was noted (Fig. 5) . Granulosa cell CART binding was not detectable in the F2 follicle at the predeviation stage and significantly increased in the F2 follicle from onset of deviation to the early dominance stage (significant effect of stage of the follicular wave, P , 0.05). A tendency was also found for reduced CART binding in the F1 follicle during the selection process (P ¼ 0.085). CART binding was higher in the F1 versus the F2 follicle at the predeviation stage but higher in the F2 versus the F1 follicle at the early dominance stage (P , 0.05).
Enhancement of Estradiol-Producing Capacity of the F2 Follicle via Intrafollicular G o/i Inhibitor (NF023) Administration at Onset of Deviation
Intrafollicular inhibition of the G o/i proteins linked to CART receptor signaling via injection of the G o/i inhibitor NF023 into the F2 follicle at onset of deviation increased follicular fluid estradiol levels by 4-fold (P , 0.05) over that of follicles injected with the inactive control inhibitor (Table 1) . Inhibitor administration had no effect on progesterone concentrations (Table 1) in the follicular fluid, but the estradiol:progesterone ratio was also increased (P , 0.05) in response to G o/i inhibitor injection (Table 1) .
DISCUSSION
The present study tested the hypothesis that intrafollicular injection of a known inhibitor of CART action (the G o/i inhibitor NFO23) would increase estradiol-producing capacity of the F2 follicle accompanying dominant follicle selection. The study also tested the hypothesis that granulosa cell CART binding is hormonally regulated and may help target CART actions to F2 follicles during the process of dominant follicle selection. The present results support these hypotheses. An increase in follicular fluid estradiol and the estradiol:progesterone ratio were observed in G o/i inhibitor-injected F2 follicles 
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versus follicles injected with the inactive form of the inhibitor, suggesting that CART suppresses estradiol-producing capacity of the F2 follicle during dominant follicle selection. Temporal changes in CART binding, including increased binding activity in the F2 follicle accompanying dominant follicle selection and greater binding in the F2 versus F1 follicle during the early dominance phase, were also noted. These differences in CART-binding activity, coupled with differences in follicular fluid CART concentrations noted in the present and previous studies [17] , support a contribution of CART to regulation of granulosa cell estradiol production in the F2 follicle during the selection process.
Results of in vitro studies suggest a dose-dependent, positive role for FSH signaling in regulation of granulosa cell CART binding following 6 days of treatment. FSH concentrations are known to decline during the process of dominant follicle selection [37] , and FSH receptor mRNA [38] [39] [40] and receptor binding [33, 35, 41, 42] do not increase during this time. However, FSH concentrations typically increase approximately 2 days before emergence of a follicular wave, peak just before or coincident with emergence, and continue to decline thereafter [37] . Therefore, it is plausible that the declining FSH concentrations in vivo during the period of time between emergence and the early dominance stage mediates the observed reduction in CART receptor binding in the F1 follicle during the selection process.
The observed differential regulation of CART receptor binding in the F1 versus F2 follicles during the selection process is of considerable interest. In general, identification of functional differences between F1 and F2 follicles before selection and the mechanisms responsible remains one of the holy grails in ovarian biology [7] . The onset of deviation is associated with acquisition of LH receptors specifically in the granulosa cells of the F1 follicle [38, 39] , and a shift from FSHto LH-dependent growth and steroidogenesis occurs [43] . It is also during this period after onset of deviation that the fate of the F2 follicle toward atresia becomes fixed [44] . Whereas the mechanisms that regulate granulosa cell CART binding in F2 follicles in vivo during the selection process remain unclear, current results do suggest that increased CART binding in the F2 follicle after onset of deviation may help potentiate inhibitory actions of CART on estradiol production during the selection process.
Treatment with the antiestrogen ICI 182 780 in vitro for 6 days totally inhibited the increase in granulosa cell estradiol production in vitro that was observed when cells were treated with a maximal stimulatory dose of FSH. It has previously been shown that estrogen stimulation increases CYP19A1 mRNA expression in bovine granulosa cells [28] and that this stimulation is greatly enhanced when estrogen and FSH are given concurrently [28] . The present results also demonstrate that FSH stimulation of estradiol production requires estrogen The results of the present study do not support a role for estradiol in regulation of CART binding in vivo, but previous studies have demonstrated that biological effects of CART on bone mass are ovary, but not estradiol, dependent. Cartpt mutant mice display indices of osteoporosis [45] , whereas female transgenic mice overexpressing Cartpt display an increase in bone mass [46] . A gender-specific increase in bone mass was observed in response to peripheral, subcutaneous CART administration in female, but not male, wild-type and Cartpt-overexpressing transgenic mice [47] . Whereas the CART-induced increase in bone mass was ameliorated in ovariectomized animals, supplementation with estradiol did not restore the CART-induced increase in bone mass, suggesting an involvement of an unknown, ovary-dependent mechanism in maintenance of CART responsiveness and regulation of bone mass [47] . Whether such unknown mechanisms also modulate CART responsiveness in bovine ovarian granulosa cells is unknown.
In the present study, CART binding increased in the F2 follicle, and CART peptide concentrations decreased in the F1 follicle during the selection process. In contrast, an effect of stage of the follicular wave on follicular fluid CART concentrations in the F2 follicle was not noted. The observed temporal regulation of follicular fluid CART concentrations in the F1 follicle is similar to what we have reported previously [17] and suggests that CART expression is highly regulated in the dominant follicle. The mechanisms responsible for decreased follicular fluid CART concentrations in the F1 follicle but increased CART binding in the F2 follicle coincident with selection have not been elucidated. However, free IGF concentrations in follicular fluid, linked to changes in specific IGF-binding proteins, are decreased in the F2 follicle but increased in the F1 follicle during this time period [48] . Previous studies have demonstrated an inhibitory effect of IGF1 on CARTPT mRNA expression by cultured granulosa cell in vitro [17] . Hence increased IGF1 bioavailability in the F1 follicle could contribute to the reduction in CART concentrations observed in the present study.
Although not an area of emphasis in the present study, the mechanisms responsible for and the implications of elevated CART and CART binding in the F1 follicles collected at the predeviation stage and the lack of CART responsiveness of F2 follicles at this stage (based on undetectable granulosa cell CART binding) are not known. Acquisition of LH receptors in bovine granulosa cells occurs at approximately the 8-mm stage [38, 39, 48] , near the time of diameter deviation, and is believed to be critical to dominant follicle selection and maintenance of dominance in cattle [44, 49] . Evidence supports a role for FSH and estradiol in promoting granulosa cell LH receptor expression in rodents [50, 51] . Thus, it is plausible that elevated CART and granulosa cell CART binding in the F1 follicle at the predeviation stage helps limit estradiol-producing capacity and temporally regulate onset of granulosa cell LH receptor expression in the F1 follicle associated with diameter deviation.
We have previously shown that CART peptide treatment impedes FSH signaling in bovine granulosa cells in vitro and that these effects can be blocked by NF023, an inhibitor of G o/i protein signaling [18, 19] . We have also shown that injection of the mature form of the CART peptide into the dominant follicle at the early dominance stage decreases both follicular fluid estradiol and granulosa cell CYP19A1 mRNA expression [17] . However, because we hypothesize that CART helps regulate estradiol-producing capacity of the F2 follicle relative to the F1 follicle accompanying selection of the dominant follicle, we tested the effects of intrafollicular injection of the same established inhibitor of CART actions (NF023). The present results show that injection of NF023 into the F2 follicle at onset of deviation results in increased follicular fluid estradiol and increased estrogen:progesterone ratio 24 h after injection. This suggests that CART signaling in the subordinate follicle suppresses estradiol production and may explain the lower follicular fluid estradiol concentrations of the F2 relative to the F1 follicle associated with atresia of the subordinate follicle [5] . We acknowledge we cannot discount a contribution of suppression of other unidentified bovine granulosa cell inhibitory G protein-linked pathways (beyond CART signaling) to the increased follicular fluid estradiol concentrations observed following injection of NF023 into the F2 follicle in vivo, but to our knowledge, such pathways in bovine granulosa cells have not yet been identified. Given our previous studies described above and the fact others have also shown that NF023 blocks CART actions on AtT20 cells [24] and hippocampal neurons [25] , we feel that the pharmacological inhibitor approach undertaken in the present study extends our knowledge of CART regulation of follicular development and strongly supports a potential inhibitory role for CART in regulation of estradiol production in the F2 follicle associated with dominant follicle selection.
Taken together, our results support the hypothesis that CART is involved in the process of dominant follicle selection in cattle. Increased understanding of the factors that regulate CARTPT expression and CART binding as well as the molecular nature of the CART receptor are critical to further elucidate the functional role of CARTPT in follicular development. FOLGER ET AL.
